Personalized Medicine: From the Average to the Individual
Series: Medicine of the future / June 29, 2026
How individual is disease, really – and what does that mean for its treatment? Personalized medicine addresses precisely this question: it regards biological diversity as the key and integrates molecular, imaging, and clinical data into individual disease profiles. Two central technologies in this field are spatial biology, which reveals the spatial distribution of biological molecules within tissues, and multi-omics, which combines analyses of different molecular layers such as genes, proteins, and metabolic processes. Researchers at Fraunhofer IIS have developed the software solution MIKAIA® to support this approach.